The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
| Title |
Phase II study of nab-paclitaxel with gemcitabine for relapsed/refractory small cell lung cancer
|
|---|---|
| Published in |
Frontiers in oncology, July 2024
|
| DOI | 10.3389/fonc.2024.1303268 |
| Pubmed ID | |
| Authors |
Margaret M. Byrne, Grerk Sutamtewagul, William Zeitler, Sarah L. Mott, Gideon K.D. Zamba, Arsenije Kojadinovic, Jun Zhang, Taher Abu-Hejleh, Gerald Clamon, Muhammad Furqan |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 August 2024.
All research outputs
#16,310,917
of 26,538,769 outputs
Outputs from Frontiers in oncology
#5,172
of 23,241 outputs
Outputs of similar age
#84,788
of 215,963 outputs
Outputs of similar age from Frontiers in oncology
#26
of 306 outputs
Altmetric has tracked 26,538,769 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23,241 research outputs from this source. They receive a mean Attention Score of 3.2. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 215,963 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 306 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.